New Waltham biotech startup aims to take cancer cells out of stealth mode
October 04, 2017 at 07:00 AM EDT
Palleon Pharmaceuticals said it will use a $47.6 million Series A round to develop drugs that make it easier for immune cells to detect and attack tumors.